Atrial fibrillation is associated with changes in atrial electrophysiology
that facilitate the initiation and persistence of the arrhythmia. The under
lying cellular and molecular mechanisms are diverse; they have intensively
been investigated over the past few years. The results, that have substanti
ally improved the understanding of the pathophysiology of atrial fibrillati
on are reviewed. On the cellular level, atrial fibrillation leads to a stro
ng shortening and an impaired rate adaptation of the action potential as we
ll as changes in action potential morphology. Atrial fibrillation is associ
ated with an altered gene expression of the L-type calcium channel (I-Ca,I-
L) and of potassium channels (I-to, I-Kl, I-KACh). The molecular mechanisms
of intraatrial conduction slowing are less well understood; changes in the
expression or distribution of gap junction proteins or a decrease of the f
ast sodium inward channel (I-Na) Seem to be involved. A trigger for many of
the observations is an overload of the myocyte cytoplasm with Ca2+ and a c
onsecutive decrease of the systolic calcium gradient, furthermore changes i
n calcium-handling proteins are detectable in atrial fibrillation. In the l
ast part, the clinical relevance and potential new therapeutic approaches a
re discussed.